ONCY — Oncolytics Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Oncolytics Biotech, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	31.2	41.3	32.1	34.9	16.9
Net Total Receivables	0.09	0.866	0.521	0.015	0.068
Prepaid Expenses
Total Current Assets	33.7	44.9	35.7	38.2	18.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.609	0.976	0.652	0.647	1.31
Other Long Term Assets
Total Assets	34.3	45.9	37.3	38.8	20.2
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.71	2.69	3.94	4.24	6.69
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9.59	9.78	10.8	11.3	14.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	24.8	36.1	26.5	27.6	5.98
Total Liabilities & Shareholders' Equity	34.3	45.9	37.3	38.8	20.2
Total Common Shares Outstanding